Dr. Michael Borger, MD

Cardiac Surgery  ·  
Male  ·  
Age 51
(9)
Insurances Accepted  ·  Save
Dr. Michael Borger, MD
"Dr. Borger is an internationally recognized cardiothoracic surgeon with expertise in complex aortic surgery, including aortic root and arch replacement and valve-sparing procedures. His clinical interests also include minimally invasive and percutaneous valve procedures, valve repair surgery, and ischemic mitral regurgitation. Academically, he has been a leader in the development of new techniques and technologies, has published over 250 scientific articles, and has spoken at and moderated numerous international conferences. A native of Canada, Dr. Borger received his cardiothoracic surgical training and PhD at the University of Toronto in 2001, and completed an additional fellowship at the Leipzig Heart Center under the supervision of Professor Fred Mohr in 2002. He subsequently took a position as staff surgeon at Toronto General Hospital, working under Dr. Tirone David, and then in Leipzig, Germany, where he was named Associate Director of the Leipzig Heart Center in 2009. Dr. Borger brings the latest techniques in aortic valve repair, valve-sparing aortic replacement, and percutaneous and hybrid approaches to chronic and acute aortic pathology. "

Risks associated with the TAVR procedure include death, stroke and major bleeding

Important Risk Information for Patients

Indications:

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic or mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the STS risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

Contraindications (Who should not use):

The Edwards SAPIEN 3 transcatheter heart valve and delivery system should not be used in patients who:

  • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
  • Have an active infection in the heart or elsewhere.

Warnings:

  • There may be an increased risk of stroke in transcatheter aortic valve replacement procedures, compared to other standard treatments for aortic stenosis in the high or greater risk population.
  • If an incorrect valve size for your anatomy is used, it may lead to heart injury, valve leakage, movement, or dislodgement.
  • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
  • The SAPIEN 3 valve may not last as long in patients whose bodies do not process calcium normally.
  • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
  • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN 3 transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

Precautions:

The long-term durability of the Edwards SAPIEN 3 transcatheter heart valve is not known at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing. Safety, performance, and durability of the SAPIEN 3 valve has not been established for placement inside a previously implanted transcatheter valve.

The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

  • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks.
  • Previous prosthetic ring in any position.
  • Previous atrial septal occlude.
  • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors.
  • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly.
  • Diseased, abnormal or irregularly shaped vessels leading to the heart. Vessels which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry.
  • Allergies to blood-thinning medications or dye injected during the procedure.
  • For a valve in valve procedure, there is a risk of leakage if the previously implanted tissue valve is not securely in place or if it is damaged. There is also the possibility that a partially detached valve leaflet from the previously implanted valve could block a blood vessel.
  • Additional pre-procedure imaging will be completed to evaluate proper sizing.

Potential risks associated with the procedure include:

  • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding.
  • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pacemaker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart, injury to the structure of the heart.
  • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise.
  • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin.
  • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling.

Additional potential risks specifically associated with the use of the heart valve include:

  • Valve movement after deployment, blockage or disruption of blood flow through the heart, need for additional heart surgery and possible removal of the SAPIEN 3 valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories.

CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician.

Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN 3, SAPIEN, and SAPIEN 3 are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

© 2017 Edwards Lifesciences Corporation. All rights reserved. PP--US-2507 v1.0

Edwards Lifesciences One Edwards Way, Irvine CA 92614 USA edwards.com

177 Fort Washington Ave # Mhb

New York, NY 10032

Contact Information

(212) 305-4980

Dr. Michael Borger, MD

Dr. Michael Borger, MD

Accepted insurance

  • EmblemHealth

*Please verify this information when scheduling an appointment.

Learn about Dr. Borger

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you.

Top Care Areas

See how frequently Dr. Borger performs your care needs compared to other doctors.

Mitral Valve Surgery
very high
more than 99% of peers
Valve Repair or Replacement (Aortic, Mitral, Tricuspid, and Pulmonary)
very high
more than 99% of peers
Aortic Valve Surgery
very high
more than 97% of peers

Dr. Borger's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

Dr. Borger's bio

This content was provided by Dr. Borger "Dr. Borger is an internationally recognized cardiothoracic surgeon with expertise in complex aortic surgery, including aortic root and arch replacement and valve-sparing procedures. His clinical interests also include minimally invasive and percutaneous valve procedures, valve repair surgery, and ischemic mitral regurgitation. Academically, he has been a leader in the development of new techniques and technologies, has published over 250 scientific articles, and has spoken at and moderated numerous international conferences. A native of Canada, Dr. Borger received his cardiothoracic surgical training and PhD at the University of Toronto in 2001, and completed an additional fellowship at the Leipzig Heart Center under the supervision of Professor Fred Mohr in 2002. He subsequently took a position as staff surgeon at Toronto General Hospital, working under Dr. Tirone David, and then in Leipzig, Germany, where he was named Associate Director of the Leipzig Heart Center in 2009. Dr. Borger brings the latest techniques in aortic valve repair, valve-sparing aortic replacement, and percutaneous and hybrid approaches to chronic and acute aortic pathology. "
Less
Read Less

Care Philosophy

This content was provided by Dr. Borger "We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person. "

1  Specialties

  • Cardiac Surgery

0  Board Certifications

Dr. Borger does not have any board certifications listed.

38  Conditions Treated

  • Aneurysm
  • Angina and Acute Coronary Syndrome
  • Aortic Aneurysm
  • Aortic Dissection
  • Aortic Ectasia
  • Aortic Embolism and Thrombosis
  • Aortic Stenosis
  • Aortic Valve Disease
  • Aortic Valve Regurgitation
  • Arrhythmias
  • Atrial Fibrillation
  • Atrial Flutter
  • Benign Tumor
  • Cancer
  • Cardiomegaly
  • Cardiomyopathy
  • Carotid Artery Disease
  • Congenital Aortic Valve Disorders
  • Congenital Heart Defects
  • Congenital Heart Disease
  • Congestive Heart Failure
  • Coronary Artery Disease (CAD)
  • Endocarditis
  • Heart Attack (Acute Myocardial Infarction)
  • Heart Disease
  • Heart Tumors, Benign
  • Mitral Valve Disease
  • Mitral Valve Regurgitation
  • Mitral Valve Stenosis
  • Pericardial Disease
  • Pulmonary Disease
  • Pulmonary Embolism
  • Pulmonary Valve Disease
  • Rheumatic Aortic Valve Disorders
  • Septal Defect
  • Thoracoabdominal Aortic Aneurysm
  • Thrombosis
  • Vascular Disease
Less
Read Less

35  Procedures

Less
Read Less

Background Check

0 Malpractice Claims

No malpractice history found for New York.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • University of Alberta Faculty of Medicine And Dentistry
    Medical School | Graduated 1991
  • University of Alberta Hospitals
    Internship Hospital | Completed 1992
  • U of Calgary, Foothills Hosp
    Residency Hospital | Completed 1993
  • Univ of Saskatchewan, Royal Univ Hosp
    Residency Hospital | Completed 1995
  • Toronto General Hospital
    Fellowship Hospital | Completed 2001
  • University of Leipzing
    Fellowship Hospital | Completed 2002

Awards & Recognition

Awards & Honors

Dr. Borger has no awards or honors listed.

Media & Publications

Dr. Borger has no media or publications listed.

Languages Spoken

  • English

Memberships & Professional Affiliations

Dr. Borger does not have any memberships or affiliations listed. If you are Dr. Borger and would like to add memberships or affiliations, please update your profile.

Dr. Borger's Reviews

Likelihood to recommend Dr. Borger

4.6

Based on 9 reviews

5 Stars
88.88888888888889%
(8)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
11.11111111111111%
(1)

Leave a review

How likely are you to recommend
Dr. Borger?
(Select your rating)
Average Wait Time
  • 16 – 30 minutes
Dr. Borger's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Michael Borger, MD
RecentHighestLowest
Reply
Dr. Borger replaced my Aortic Valve May 2/ 2003 at Toronto General Hospital,he was the new kid on the block. I lucked out, and I'm still ticking, like a clock. It was during Sars and he and the nurses were beyond professional and made you feel important. Don't know if you read these Doc.,just...Read More
Was this helpful?
thumbs up icon option
thumbs down icon option
Ken Bowers in Bracebridge On. – Jan 06, 2018
×Post a ResponseAre you Dr. Michael Borger, MD?
Reply
Dr. Borger operated on my husband. He had a triple bypass done.. I would recommend him to everyone. He is an excellent doctor.
Was this helpful?
thumbs up icon option
thumbs down icon option
Poughkeepsie, NY – Oct 18, 2017
×Post a ResponseAre you Dr. Michael Borger, MD?
Reply
Dr. Borger is an amazing surgeon. For such a medical taken, he is low key and quite calming. I felt comforted knowing he was the doctor performing aortic root repair on my daughter, a skill he learned from the man who invented the procedure. He performed a 4-7 hour surgery in 3.5 hours. Something...Read More
Was this helpful?
thumbs up icon option
thumbs down icon option
Ilana Akoundi in New York, NY – May 18, 2017
×Post a ResponseAre you Dr. Michael Borger, MD?
Reply
Damn fine job of replacing my defective aortic valve and root. Here's a guy who deserves to do a stupid end-zone dance every time he does his job, but probably doesn't.
Was this helpful?
thumbs up icon option
thumbs down icon option
Geof in Upper Saddle River, NJ – Jan 10, 2017
×Post a ResponseAre you Dr. Michael Borger, MD?
Reply
Dr Borger repaired my Mitral Valve in December 2015. Dr. Borger and his entire support and office staff made this difficult experience as easy and effective as possible. From the initial appointment to leaving the hospital I was treated like I was his only patient. I would fully recommend him.
Was this helpful?
thumbs up icon option5
thumbs down icon option1
Rich S in Lambertville, NJ – May 11, 2016
×Post a ResponseAre you Dr. Michael Borger, MD?

Leave a review

How was your experience with Dr. Borger?

Visit Dr. Borger

Now Accepting New Patients

Dr. Borger accepts 1 insurance carrier

  • EmblemHealth
    Health Insurance Plan of Greater New York (HIP) PPO

*Please verify this information when scheduling an appointment.